Clinical trials
Macular Edema trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Vienna | 7 |
| Bayer | 4 |
| Novartis Pharmaceuticals | 3 |
| Hoffmann-La Roche | 2 |
| Allergan | 1 |
| Augenabteilung Allgemeines Krankenhaus Linz | 1 |
| Clearside Biomedical, Inc. | 1 |
| Luigi Rondas | 1 |
| Maastricht University Medical Center | 1 |
| The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Edema | 24 |
| Retinal Vein Occlusion | 8 |
| Cataract | 3 |
| Diabetes Mellitus | 3 |
| Diabetic Retinopathy | 3 |
| Corneal Diseases | 1 |
| Eye Diseases | 1 |
| Lens Diseases | 1 |
| Postoperative Complications | 1 |
| Retinal Diseases | 1 |
Trials
Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.